Search Results - Angela Alexander
- Showing 1 - 4 results of 4
-
1
De Novo Self-Assembling Peptides Mediate the Conversion of Temozolomide and Delivery of a Model Drug into Glioblastoma Multiforme Cells by Megan Pitz, Margaret Elpers, Alexandra Nukovic, Sarah Wilde, Arica Jordan Gregory, Angela Alexander-Bryant
Published in Biomedicines (2022-09-01)Get full text
Article -
2
Fusogenic peptide delivery of bioactive siRNAs targeting CSNK2A1 for treatment of ovarian cancer by Timothy Samec, Kharimat Lora Alatise, Jessica Boulos, Serena Gilmore, Anthony Hazelton, Carleigh Coffin, Angela Alexander-Bryant
Published in Molecular Therapy: Nucleic Acids (2022-12-01)Get full text
Article -
3
A phase Ib/II trial of neoadjuvant neratinib added to standard therapy in patients with HER2-positive or HR-positive/HER2-negative inflammatory breast cancer (including stage III a... by Bora Lim, Angela Marx, Megumi Kai, Angela Alexander, Roland Bassett, Wencai Ma, Jie Willey, Huiming Sun, Azadeh Nasrazadani, Mohammad M. Mohammad, Jianhua Zhang, Anthony Lucci, Susie X. Sun, Michael C. Stauder, Gary J. Whitman, Huong Le-Petross, Vicente Valero, Wendy A. Woodward, Rachel M. Layman
Published in Therapeutic Advances in Medical Oncology (2025-10-01)Get full text
Article -
4
Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancer by Xiaoping Wang, Li Zhao, Xingzhi Song, Xiaogang Wu, Savitri Krishnamurthy, Takashi Semba, Shan Shao, Mark Knafl, Larry W. Coffer, Angela Alexander, Anita Vines, Swetha Bopparaju, Wendy A. Woodward, Randy Chu, Jianhua Zhang, Clinton Yam, Lenora W. M. Loo, Azadeh Nasrazadani, Le-Petross Huong, Scott E. Woodman, Andrew Futreal, Rare Tumor Initiative Team, Debu Tripathy, Naoto T. Ueno
Published in npj Precision Oncology (2024-11-01)Get full text
Article
